JY
ONCO icon

Jeff Yass’s Onconetix ONCO Stock Holding History

Jeff Yass’s Portfolio ONCO Stock Details ONCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2
Closed -$6.46K – 13179
2024
Q4 		$6.46K Buy
+2
New +$20.2K ﹤0.01% 12001
2024
Q3 		– Sell
-1
Closed -$19K – 12734
2024
Q2 		$19K Buy
+1
New +$25.4K ﹤0.01% 11675
2023
Q3 		– Hold
0
– -$40.4K – 12681
2023
Q2 		– Hold
0
– – – 11414

Other funds holding ONCO

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Zurich Cantonal Bank
Zurich Cantonal Bank Zurich, Switzerland $52.2B AUM 40.82% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

Jeff Yass's ONCO Position: Q1 2025 in Review

Jeff Yass sold out of Onconetix (ONCO) in Q1 2025, closing a stake of 2 shares — an estimated $6.46K sold.

Jeff Yass first reported a position in ONCO in Q2 2024 and held it in 2 quarters. The position peaked at $19K in Q2 2024. 10 funds tracked by Wall St. Rank hold ONCO as of Q1 2025.

  • Jeff Yass reported no remaining Onconetix position as of Q1 2025 after selling out during the quarter.
  • Jeff Yass sold 2 Onconetix shares in Q1 2025, an estimated $6.46K.
  • Jeff Yass first reported a position in Onconetix in Q2 2024 and held it in 2 quarters.
  • Jeff Yass's Onconetix position peaked at $19K in Q2 2024.
  • 10 funds tracked by Wall St. Rank held Onconetix as of Q1 2025.

Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.